EP3644970
NÝ LYFJAFORM AF BELÍNÓSTATI TIL INNTÖKU
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
29.6.2018EP published:
9.2.2022EP application number:
18737225.5
EP translation filed:
30.3.2022Grant published:
15.5.2022EPO information:
European Patent Register
Max expiry date:
28.6.2038Expiry date:
28.6.2026Next due date:
30.6.2026
Title in English:
NEW ORAL FORMULATIONS OF BELINOSTATLanguage of the patent:
English
Timeline
Today
29.6.2018EP application
9.2.2022EP Publication
30.3.2022Translation submitted
15.5.2022Registration published
28.6.2026Expires
Owner
Name:
ACROTECH BIOPHARMA LLCAddress:
279 Princeton Hightstown Road, 08520, East Windsor, NJ, US
Inventor
Name:
PIVETTE, PerrineAddress:
94140 Alfortville, FR
Name:
LEMARCHAND, CarolineAddress:
75014 Paris, FR
Name:
YATES, IanAddress:
Bend Oregon 97701, US
Name:
BLOOM, CoreyAddress:
Bend Oregon 97701, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201762527684 PDate:
30.6.2017Country:
US
Number:
17305853Date:
3.7.2017Country:
EP
Classification
Categories:
A61K 9/16, A61K 31/18, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 1.6.2022
Expires: 28.6.2023
Payer: Patice ehf.
Number: 6
Paid: 11.6.2023
Expires: 28.6.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 31.5.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 18.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.